What do systematic reviews say?

Deferasirox vs placebo

The review found no eligible studies for this question.

• Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Deferasirox vs deferiprone

The review found no eligible studies for this question.

• Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Deferasirox vs combined deferasirox and deferiprone

• Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 participants
  GRADE not reported

Deferasirox vs deferoxamine

Deferasirox probably leads to lower responder analysis II (responder: LIC 1 to less than 7 mg Fe/g dw) compared with deferoxamine (moderate certainty).

• Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
  RR 0.8 [0.69, 0.92]
  1 study · 553 participants
  Moderate

Combined deferasirox and deferiprone vs deferiprone and deferoxamine

The review found no eligible studies for this question.

• Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Deferasirox and deferoxamine vs deferoxamine

The review found no eligible studies for this question.

• Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Combined deferasirox and deferiprone vs deferiprone

• Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 participants
  GRADE not reported